OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The predictive utility of circulating PCSK9 levels on diabetes mellitus
Jia Peng, Cheng‐Gang Zhu, Jian‐Jun Li
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Jia Peng, Cheng‐Gang Zhu, Jian‐Jun Li
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia
Yajnavalka Banerjee, Anca Pantea Stoian, Arrigo F.G. Cicero, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 1, pp. 9-20
Closed Access | Times Cited: 42
Yajnavalka Banerjee, Anca Pantea Stoian, Arrigo F.G. Cicero, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 1, pp. 9-20
Closed Access | Times Cited: 42
Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus
Laurenz T. Fischer, Daniel A. Hochfellner, Lisa Knoll, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Laurenz T. Fischer, Daniel A. Hochfellner, Lisa Knoll, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
Zhicai Feng, Xiangyu Liao, Hao Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 4
Zhicai Feng, Xiangyu Liao, Hao Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 4
Serum proprotein convertase subtilisin/Kexin type 9 and vascular disease in type 2 diabetic patients
Giuseppe Armentaro, Federico Carbone, Velia Cassano, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 3
Open Access | Times Cited: 4
Giuseppe Armentaro, Federico Carbone, Velia Cassano, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 3
Open Access | Times Cited: 4
Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study
Hiroki Yamagata, Aiko Hayashi, Yoich Yoshida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Hiroki Yamagata, Aiko Hayashi, Yoich Yoshida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
